S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Lithium Overdose: Can These 2 Lithium Stocks Recover in 2024?
North Carolina medical marijuana sales begin at Cherokee store
'Civil War’ continues box-office campaign at No. 1
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
Intuitive Surgical Leads the Robotic Surgery Movement
Stock market today: Wall Street eyes corporate earnings after last week's Big Tech selloff
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Lithium Overdose: Can These 2 Lithium Stocks Recover in 2024?
North Carolina medical marijuana sales begin at Cherokee store
'Civil War’ continues box-office campaign at No. 1
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
Intuitive Surgical Leads the Robotic Surgery Movement
Stock market today: Wall Street eyes corporate earnings after last week's Big Tech selloff
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Lithium Overdose: Can These 2 Lithium Stocks Recover in 2024?
North Carolina medical marijuana sales begin at Cherokee store
'Civil War’ continues box-office campaign at No. 1
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
Intuitive Surgical Leads the Robotic Surgery Movement
Stock market today: Wall Street eyes corporate earnings after last week's Big Tech selloff
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Lithium Overdose: Can These 2 Lithium Stocks Recover in 2024?
North Carolina medical marijuana sales begin at Cherokee store
'Civil War’ continues box-office campaign at No. 1
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
Intuitive Surgical Leads the Robotic Surgery Movement
Stock market today: Wall Street eyes corporate earnings after last week's Big Tech selloff
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro

Palisade Bio (PALI) News Today

$4.74
+0.03 (+0.64%)
(As of 08:37 AM ET)
SourceHeadline
benzinga.com logoLooking Into Palisade Bio's Recent Short Interest
benzinga.com - April 19 at 2:14 PM
markets.businessinsider.com logoAnalysts’ Opinions Are Mixed on These Healthcare Stocks: SAGE Therapeutics (SAGE) and Palisade Bio (PALI)
markets.businessinsider.com - April 17 at 5:31 PM
MarketBeat logoPalisade Bio (NASDAQ:PALI) Given Buy Rating at Maxim Group
americanbankingnews.com - April 17 at 3:56 AM
msn.com logoHow Apple Car Key Works (and Why It Still Hasn’t Caught On)
msn.com - April 17 at 2:29 AM
msn.com logoPalisade Bio stock rallies nearly 100% on colitis drug analysis
msn.com - April 16 at 9:28 PM
marketwatch.com logoPalisade Bio Shares Surge 80% After Lab Study Results for Ulcerative Colitis Treatment
marketwatch.com - April 16 at 4:28 PM
msn.com logoWhy Palisade Bio Stock Is Soaring Today
msn.com - April 16 at 4:28 PM
investorplace.com logoWhy Is Palisade Bio (PALI) Stock Up 57% Today?
investorplace.com - April 16 at 11:22 AM
marketbeat.com logo
marketbeat.com - April 16 at 9:39 AM
finance.yahoo.com logoPalisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients’ Stool
finance.yahoo.com - April 16 at 8:43 AM
globenewswire.com logoPalisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients' Stool
globenewswire.com - April 16 at 8:30 AM
uk.investing.com logoPalisade Bio advances ulcerative colitis treatment to Phase 1 study
uk.investing.com - April 12 at 12:54 PM
globenewswire.com logoPalisade Bio to Participate in the Virtual Investor Lunch Break Event
globenewswire.com - April 11 at 9:15 AM
msn.com logoPalisade Bio stock slides 8% amid colitis drug presentation
msn.com - April 10 at 1:23 PM
finance.yahoo.com logoPalisade Bio Presents Development Overview of PALI-2108 at the IBD Innovate: Product Development for Crohn’s & Colitis™
finance.yahoo.com - April 10 at 8:23 AM
globenewswire.com logoPalisade Bio Presents Development Overview of PALI-2108 at the IBD Innovate: Product Development for Crohn's & Colitis™
globenewswire.com - April 10 at 8:15 AM
marketbeat.com logo
marketbeat.com - April 8 at 6:04 AM
morningstar.com logoPalisade Bio Inc 7NS
morningstar.com - April 6 at 12:52 AM
globenewswire.com logoPalisade Bio Announces 1-for-15 Reverse Stock Split
globenewswire.com - April 3 at 5:30 PM
finance.yahoo.com logoPalisade Bio Reports Year End 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - March 27 at 9:56 AM
investorplace.com logoPALI Stock Earnings: Palisade Bio Beats EPS for Q4 2023
investorplace.com - March 27 at 1:03 AM
finance.yahoo.com logoPalisade Bio to Present at Digestive Disease Week (DDW) 2024
finance.yahoo.com - February 15 at 3:59 PM
globenewswire.com logoPalisade Bio to Present at Digestive Disease Week (DDW) 2024
globenewswire.com - February 15 at 8:35 AM
finanznachrichten.de logoPalisade Bio, Inc.: Palisade Bio Provides Corporate Update and Reiterates Guidance
finanznachrichten.de - February 13 at 3:55 PM
marketwatch.com logoPalisade Names Donald Williams Chairman, Cuts Board Size in Half
marketwatch.com - February 13 at 10:55 AM
finance.yahoo.com logoPalisade Bio Provides Corporate Update and Reiterates Guidance
finance.yahoo.com - February 13 at 10:55 AM
finance.yahoo.com logoPalisade Bio Announces Formation of Clinical Advisory Board with Appointments of Preeminent Key Opinion Leaders
finance.yahoo.com - February 8 at 12:21 PM
msn.com logoFTC more `focused' on stopping bad deals after Amazon-iRobot - report
msn.com - January 31 at 12:15 PM
msn.com logoPalisade Bio Shares Updates and Drug Candidate Progress
msn.com - January 30 at 4:08 PM
finance.yahoo.com logoPalisade Bio Announces Exercise of Previously Issued Warrants for $2.5 Million
finance.yahoo.com - January 30 at 10:24 AM
marketwatch.com logoPalisade Bio Shares Drop 23% After Warrants Exercised
marketwatch.com - January 30 at 10:24 AM
finance.yahoo.com logoPalisade Bio Announces Exercise of Previously Issued Warrants for $2.5 Million
finance.yahoo.com - January 30 at 10:24 AM
investorplace.com logoWhy Is Palisade Bio (PALI) Stock Up 100% Today?
investorplace.com - January 29 at 3:03 PM
finanznachrichten.de logoPalisade Bio, Inc.: Palisade Bio Announces Positive Preclinical Data of Lead Program PALI-2108 at the 2024 Crohn's & Colitis Congress
finanznachrichten.de - January 29 at 12:28 PM
msn.com logoPalisade stock soars 150% on cancelled offering, potential reverse split
msn.com - January 29 at 12:28 PM
seekingalpha.com logoPalisade stock soars 150% on canceled offering, potential reverse split
seekingalpha.com - January 29 at 12:28 PM
finance.yahoo.com logoPalisade Bio Announces Positive Preclinical Data of Lead Program PALI-2108 at the 2024 Crohn’s & Colitis Congress
finance.yahoo.com - January 29 at 12:28 PM
marketbeat.com logo
marketbeat.com - January 29 at 9:49 AM
marketwatch.com logoStocks to Watch: Palisade Bio
marketwatch.com - January 26 at 7:53 PM
marketwatch.com logoPalisade Bio Up 40% After-Hours, Withdraws S-1 Filing and May Enact Reverse Split
marketwatch.com - January 26 at 7:53 PM
finance.yahoo.com logoPalisade Bio Selected for Poster Presentation at the 2024 Crohn’s & Colitis Congress
finance.yahoo.com - January 9 at 1:35 PM
tmcnet.com logoPalisade Bio Selected for Poster Presentation at the 2024 Crohn's & Colitis Congress
tmcnet.com - January 9 at 8:34 AM
msn.com logoPalisade Bio files to sell its shares
msn.com - December 29 at 5:28 PM
markets.businessinsider.com logoPalisade Bio Reports Milestone Payment To Giiant Pharma From US Crohn's And Colitis Foundation
markets.businessinsider.com - December 28 at 10:24 AM
finance.yahoo.com logoPalisade Bio Announces Receipt of Second Milestone Payment from the US Crohn’s and Colitis Foundation for Development of PALI-2108
finance.yahoo.com - December 28 at 10:24 AM
benzinga.com logoPalisade Bio Stock (NASDAQ:PALI) Dividends: History, Yield and Dates
benzinga.com - December 19 at 8:46 AM
morningstar.com logoPalisade Bio Inc PALI
morningstar.com - December 17 at 1:08 AM
msn.com logoPalisade Bio GAAP EPS of -$0.49 misses by $0.08
msn.com - November 11 at 9:54 AM
benzinga.com logoRecap: Palisade Bio Q3 Earnings
benzinga.com - November 10 at 12:28 PM
finance.yahoo.com logoPalisade Bio to Participate at the Virtual Investor Ask the CEO Conference
finance.yahoo.com - October 11 at 12:52 PM
Get Palisade Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for PALI and its competitors with MarketBeat's FREE daily newsletter.

The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

PALI Media Mentions By Week

PALI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PALI
News Sentiment

0.35

0.48

Average
Medical
News Sentiment

PALI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PALI Articles
This Week

12

1

PALI Articles
Average Week

Get Palisade Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for PALI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:PALI) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners